Glyconics
4 known investors
Find your way into Glyconics
Glyconics develops medical diagnostic devices using spectroscopy (light-with-matter technology) to support low-cost medical diagnosis and disease management for patients and healthcare practice.
Founders & leadership
AR

Andrew RoundChief Executive Officer (ad interim)
DP
Dr. Päivi Maria PaldániusChief Medical Officer & Chief Operating Officer
SC
Sebastien Cuvelier MussalianChief Technology Officer
DP

Dr. Phil TadayHead of R&D
PJ
Paul JessonChief Finance Officer
Investors · 4
Anglia Capital GroupNorwich
Boundary CapitalreportedNorthampton · $190.5K – $635K
Deepbridge CapitalreportedChester
Also in the syndicate · 1
Wealth Clublead
Funding
SEC filings, press & company announcements- Undisclosed amountEnterprise Investment Scheme (EIS) funding roundNov 2021 · 2 sources
Deepbridge Capital (lead), Wealth Club (lead), Boundary Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Glyconics do?
- Glyconics develops medical diagnostic devices using spectroscopy (light-with-matter technology) to support low-cost medical diagnosis and disease management for patients and healthcare practice.
- Who are Glyconics's investors?
- Glyconics's investors include Anglia Capital Group, Boundary Capital, Deepbridge Capital.
